Canada · How much has Tryptamine Therapeutics raised?
Tryptamine Therapeutics has raised $4.2M across 1 round since 2024.
Canada · Funded startup
Who invested in Tryptamine Therapeutics
One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Tryptamine Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$4.2Mraised across 1 round since 2024, from 1 source
- Latest round
- Round, $4.2MMay 2024
- Investors
- 0
The rounds
- May 2024Round$4.2M
No investor was named in the report.
Source recorded
Founders and team
From Tryptamine Therapeutics's own website: 10 on the team.
- Jason CarrollChief Executive Officer
- Hamish GeorgeCFO & Company Secretary
- Jim O'NeillChief Financial Officer
- Peter MolloyChief Business Officer
- Chris NtoumenopoulosExecutive Director
- Daniel TillettNon-Executive Director
- David CastleConsultant Medical Officer
- Gage JullNon Executive Director
- Herwig JanssenChairman
- Mark DaviesChairman
Quick answers about Tryptamine Therapeutics
When did Tryptamine Therapeutics last raise?
Tryptamine Therapeutics's most recent round was an Undisclosed round of $4.2M in May 2024.
What was Tryptamine Therapeutics's biggest round?
Its most recent round, $4.2M in May 2024, is also its largest on record.
What stage is Tryptamine Therapeutics at?
Tryptamine Therapeutics's latest named round is an Undisclosed round, in May 2024.
Where is Tryptamine Therapeutics based?
Tryptamine Therapeutics is based in Canada.
Companies like Tryptamine Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.